CAS 2434-56-2

4,6-Pyrimidinediamine

Description:

4,6-Pyrimidinediamine, with the CAS number 2434-56-2, is an organic compound characterized by its pyrimidine ring structure, which features two amino groups (-NH2) at the 4 and 6 positions. This compound is typically a white to off-white solid and is soluble in water and various organic solvents, making it versatile for different applications. It is primarily used in the synthesis of pharmaceuticals, agrochemicals, and dyes due to its ability to participate in various chemical reactions, such as nucleophilic substitutions and coupling reactions. The presence of amino groups enhances its reactivity and allows for further functionalization. Additionally, 4,6-Pyrimidinediamine may exhibit biological activity, which can be of interest in medicinal chemistry. Safety data indicates that, like many amines, it should be handled with care to avoid potential health hazards, including skin and respiratory irritation. Proper storage and handling protocols are essential to ensure safety and stability.

Formula: C₄H₆N₄

InChI: InChI=1/C4H6N4/c5-3-1-4(6)8-2-7-3/h1-2H,(H4,5,6,7,8)

SMILES: c1c(N)nc[nH]c1=N

Synonyms:

• 4,6-Diaminopyrimidine
• Pyrimidine-4,6-Diamine

4,6-Diaminopyrimidine

CAS: 2434-56-2

Formula: C₄H₆N₄

Purity: >98.0%(GC)(T)

Color and Shape: White to Almost white powder to crystal

Molecular weight: 110.12

Ref: 3B-D3648

4,6-DIAMINOPYRIMIDINE

CAS: 2434-56-2

Formula: C₄H₆N₄

Purity: 97%

Color and Shape: Solid

Molecular weight: 110.1172

Ref: IN-DA003KIX

4,6-Diaminopyrimidine

CAS: 2434-56-2

4,6-Diaminopyrimidine

Purity: 98%

Molecular weight: 110.12g/mol

Ref: 54-OR302359

4,6-Diaminopyrimidine

CAS: 2434-56-2

4,6-Diaminopyrimidine is a potent inhibitor of epidermal growth factor receptor. It has been shown to inhibit the production of soluble guanylate cyclase and cGMP in vitro and in vivo. This drug has also been shown to inhibit cancer cell growth in vitro and in vivo. 4,6-Diaminopyrimidine has potential clinical relevance as an anticancer agent due to its ability to inhibit the kinases necessary for cancer proliferation. This drug also has pharmacokinetic properties that are favorable for anticancer drugs, including low plasma protein binding, high clearance rate, and short half-life. The activity of this drug was tested on hepg2 cells (human hepatoma) with an inhibitory effect on growth factor receptors such as EGFR and PDGFRs

Formula: C₄H₆N₄

Purity: Min. 95%

Molecular weight: 110.12 g/mol

Ref: 3D-FD149826

4,6-Diaminopyrimidine

CAS: 2434-56-2

Formula: C₄H₆N₄

Purity: 98%

Color and Shape: Solid, White to very pale yellow

Molecular weight: 110.12

Ref: 10-F092375